Found 5 matching trials
Safety, Tolerability, Pharmacokinetics, and Efficacy of AZD2811 Nanoparticles as Monotherapy or in Combination in Acute Myeloid Leukemia Participants.
PHASE1This is a Phase I/II clinical study to determine the maximum tolerated dose...
AZD2811 and Durvalumab (MEDI4736) Combination Therapy in Relapsed Small Cell Lung Cancer
PHASE2Samsung Medical Centre, Seoul, Korea. Additional 0\~5 Korea Lung Cancer Con...
Location
Samsung Medical Center
Study of AZD2811 + Durvalumab in ES-SCLC
PHASE2A Phase II Multicenter, Open-Label, Single Arm Study to Determine the Effic...
Status
Active Not Recruiting
A Phase I Study of Safety, Tolerability, and PK of AZD2811 in Patients With Advanced Solid Tumors.
PHASE1This Phase I study is primarily designed to evaluate the safety and tolerab...
AZD 2811 Monotherapy in Relapsed Small Cell Lung Cancer Patients [SUKSES-N3]
PHASE2This study is a single arm, multi-center phase II study of AZD 2811 monothe...
Location
Samsung Medical center